Articles related to All Specialties

BQ.1 and BQ.1.1 together now comprise more than 50% of all COVID cases in the US. Their rapid rise – with prediction that these variants will account for more than 80% of infections by Jan. 1 – lead FDA to remove the emergency use authorization for bebtelovimab, and recommend bivalent boosters and the use of ritonavir-nirmatrelvir, remdesivir, and molnupiravir for treatment of infection.

The film focuses on embalmers and funeral directors who claim to be coming forward to share their concerns over “unusual blood clots” found during prepared for burial, and Ryan Cole, MD, a promoter of false claims about the COVID vaccines and cancer. In the end, it is a combination of lies, theatrics, and scare tactics that rehash already-debunked claims.

Some of the key findings of this meta-analysis of antiviral therapy in the outpatient setting include: (treatment vs no-treatment) Probable reduction of hospitalization with Nirmatrelvir–ritonavir and casirivimab–imdevimab (1% vs 6%) Probable reduction in all-cause mortality with Nirmatrelvir–ritonavir (0% vs 1%) Probable improved recovery with regdanvimab (87% vs 72%) Four-day reduction in time to recovery with casirivimab-imdevimab Possible reduction in recovery rates with hydroxychloroquine

In this trial involving 29 healthcare facilities in 4 countries from May 2020 through April 2022, PCR-confirmed COVID infection occurred in approximately 10.5% of the mask group versus approximately 9.3% of the N95 group.

This physician relates his struggle with drinking that was mostly “internal, with few external consequences” as he puts it — just a few occasional red lights as he looked at how his alcohol use was touching his relationships with himself, his wife, and his kids.

Genetic tools such as CRISPR could enable creating a close approximation Neanderthal or other lost species DNA. Harvard geneticist George Church, PhD, argued some potential benefits to humans. But what are the potential implications and how should the question be weighed?